Fig. 3.
PCR-based methylation assay of the p15INK4B and p16INK4A genes. Results of various clinical subtypes are shown: no. 1, RA (patient no. 32); no. 2, RA (patient no. 2); no. 3, RARS (patient no. 31); no. 4, RAEB (patient no. 8); no. 5, OL (patient no. 3); no. 6, OL (patient no. 4); no. 7, OL (patient no. 26). (+), DNA digested by the methylation-sensitive restriction enzyme Eco52I; (−), undigested DNA. DNAs from some clinical samples digested by Eco52I were amplified by the primer set flanking the Eco52I site in the exon 1 of p15INK4B gene, suggesting that the p15INK4B gene is methylated; whereas none of clinical samples were amplified by the primer set for the p16INK4A gene, suggesting that the p16INK4A gene is not methylated. In ML1, the p16INK4A gene was deleted homozygously.12